GET IN TOUCH
Back to News

On Demand Webinar:Targeted Protein Degradation in Inflammation and Cancer Therapy

Duration: 1 hour

FEATURED SPEAKERS

Dr Amar Thyagarajan

Global Strategy Head &
Head of NA BD
Aragen

Venkatesh Babu
Jayaraman

Principal Scientific Manager
Aragen

Did you miss Aragen’s recent webinar on Targeted Protein Degradation in Inflammation and Cancer Therapy? You can now access the recorded webinar and the Q&A transcript of the session by filling out a quick form.

The webinar focuses on our efforts with PROTACs in the areas of Inflammation and Cancer. Our speakers discuss challenges and opportunities to develop PROTACs in the areas of Autoimmune and Inflammatory Diseases driven by IL-1R/TLR1 signaling and inflammasome activation, and in potentially undruggable epigenetic pathways that involve bromodomain proteins, histone acetyltransferases and deacetylases.

During this session, you will learn about:

  • PROTAC technology and challenges in the field
  • Opportunities and strategies to develop PROTACs in Cancer and Inflammation
  • Screening PROTACs: available tools and assays for mechanistic profiling
  • DMPK optimization for oral bioavailability

    Please fill out the form and we will contact you shortly






    Learn more about our end-to-end capabilities